Transplantation of stem cells into the spinal cords of 12 people with ALS has proven safe and well-tolerated, with no long-term complications

Posted on Wednesday, April 4, 2012 - 06:00, By: Amy Madsen
Neuralstem's spinal cord stem cells, and the surgical technique used to transplant them, proved to be safe and well-tolerated in a phase 1 clinical trial in 12 people with amyotrophic lateral sclerosis (ALS). Although the trial wasn't designed to show efficacy, one participant showed signs of...

CK-2017357 is being tested in combination with riluzole; Neuralstem is testing its stem cells in the cervical region of the spinal cord

Posted on Thursday, November 10, 2011 - 15:43, By: Amy Madsen
Editor's note 3/19/12: This story has been updated to reflect that Neuralstem has begun testing its stem cells in the cervical (neck) region of the spinal cord. Two human clinical trials to test therapies in amyotrophic lateral sclerosis (ALS) are moving forward.

 ‘Smooth progress' reported in Neuralstem's human clinical trial of neural stem cells; FDA permission sought to proceed to cervical injections

Posted on Friday, June 17, 2011 - 11:21, By: Amy Madsen
Maryland biotherapeutics company Neuralstem has announced favorable results from the first part of a phase 1 trial to test the safety of its experimental spinal cord stem cell treatment in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease).